BDNF-ERK-CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice

Journal of Psychiatry and Neuroscience

Volumn 39, Issue 5, 2014, Pages 348-359

  Yi, Li Tao ^a   Li, Jing ^a   Liu, Bin Bin ^a   Luo, Liu ^a   Liu, Qing ^a   Geng, Di ^a  

^a HUAQIAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FLUOXETINE; MICRORNA 132; MITOGEN ACTIVATED PROTEIN KINASE; OLEANOLIC ACID; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPSIN I; ANTIDEPRESSANT AGENT; CREB1 PROTEIN, MOUSE; DLGH4 PROTEIN, MOUSE; GUANYLATE KINASE; MEMBRANE PROTEIN; MICRORNA; MIRN132 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; BEHAVIORAL STRESS; BRAIN FUNCTION; CELL PROLIFERATION; CHRONIC UNPREDICTABLE MILD STRESS; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NERVE CELL; NONHUMAN; NOVELTY SUPPRESSED FEEDING TEST; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STRESS; SUCROSE PREFERENCE TEST; WESTERN BLOTTING; ANIMAL; CHRONIC DISEASE; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; MENTAL STRESS; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; UNCERTAINTY; UPREGULATION;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHRONIC DISEASE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GUANYLATE KINASE; HIPPOCAMPUS; MALE; MEMBRANE PROTEINS; MICE, INBRED ICR; MICRORNAS; NEUROGENESIS; NEURONS; OLEANOLIC ACID; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; UNCERTAINTY; UP-REGULATION;

EID: 84906814253     PISSN: 11804882     EISSN: 14882434     Source Type: Journal    
DOI: 10.1503/jpn.130169     Document Type: Article

References (51)

1. Papakostas GI, Fava M, Thase ME. Treatment of SSRI-resistant depression: a meta-analysis comparing within-versus across-class switches. Biol Psychiatry 2008;63:699-704.
2. Angelucci F, Brene S, Mathe AA. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005;10:345-52.
3. Castrén E, Rantamaki T. The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Dev Neurobiol 2010;70:289-97.
4. Li W, Keifer J. Rapid enrichment of presynaptic protein in boutons undergoing classical conditioning is mediated by brain-derived neurotrophic factor. Neuroscience 2012;203:50-8.
5. Fahnestock M, Marchese M, Head E, et al. BDNF increases with behavioral enrichment and an antioxidant diet in the aged dog. Neurobiol Aging 2012;33:546-54.
6. Rantamäki T, Hendolin P, Kankaanpaa A, et al. Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 2007;32:2152-62.
7. Zhang Y, Gu F, Chen J, et al. Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Res 2010;1366:141-8.
8. O'Leary OF, Wu X, Castren E. Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling. Psychoneuroendocrinology 2009;34:367-81.
9. Taliaz D, Stall N, Dar DE, et al. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry 2010;15:80-92.
10. Saarelainen T, Hendolin P, Lucas G, et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 2003;23:349-57.
11. Monteggia LM, Luikart B, Barrot M, et al. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 2007;61:187-97.
12. Vo N, Klein ME, Varlamova O, et al. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci U S A 2005;102:16426-31.
13. Wayman GA, Davare M, Ando H, et al. An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci U S A 2008;105:9093-8.
14. Remenyi J, Hunter CJ, Cole C, et al. Regulation of the miR-212/132 locus by MSK1 and CREB in response to neurotrophins. Biochem J 2010;428:281-91.
15. Magill ST, Cambronne XA, Luikart BW, et al. microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci U S A 2010;107:20382-7.
16. Kawashima H, Numakawa T, Kumamaru E, et al. Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression. Neuroscience 2010;165:1301-11.
17. Lee S, Kim DH, Lee CH, et al. Antidepressant-like activity of the aqueous extract of Allium macrostemon in mice. J Ethnopharmacol 2010;131:386-95.
18. Rong ZT, Gong XJ, Sun HB, et al. Protective effects of oleanolic acid on cerebral ischemic damage in vivo and H(2)O(2)-induced injury in vitro. Pharm Biol 2011;49:78-85.
19. Yi LT, Li J, Liu Q, et al. Antidepressant-like effect of oleanolic acid in mice exposed to the repeated forced swimming test. J Psychopharmacol 2013;27:459-68.
20. Jiang B, Xiong Z, Yang J, et al. Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signalling pathway and neurogenesis in the hippocampus. Br J Pharmacol 2012;166:1872-87.
21. Yan HC, Qu HD, Sun LR, et al. Fuzi polysaccharide-1 produces antidepressant-like effects in mice. Int J Neuropsychopharmacol 2010;13:623-33.
22. Yi LT, Liu BB, Li J, et al. BDNF signaling is necessary for the antidepressant-like effect of naringenin. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:135-41.
23. Choi SK, Galan M, Partyka M, et al. Chronic inhibition of epidermal growth factor receptor tyrosine kinase and extracellular signalregulated kinases 1 and 2 (ERK1/2) augments vascular response to limb ischemia in type 2 diabetic mice. Am J Pathol 2012;180:410-8.
24. Wang ZQ, Chen XC, Yang GY, et al. U0126 prevents ERK pathway phosphorylation and interleukin-1beta mRNA production after cerebral ischemia. Chin Med Sci J 2004;19:270-5.
25. Li J, Zhou Y, Liu BB, et al. Nobiletin ameliorates the deficits in hippocampal BDNF, TrkB, and synapsin I induced by chronic unpredictable mild stress. Evid Based Complement Alternat Med 2013;2013:359682.
26. Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805-9.
27. Iijima M, Fukumoto K, Chaki S. Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test. Behav Brain Res 2012;235:287-92.
28. Cheng HY, Dziema H, Papp J, et al. The molecular gatekeeper Dexras1 sculpts the photic responsiveness of the mammalian circadian clock. J Neurosci 2006;26:12984-95.
29. Hu K, Xie YY, Zhang C, et al. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci 2012;13:115.
30. Lee JJ, Jin YR, Lim Y, et al. Oleanolic acid, a pentacyclic triterpenoid, induces rabbit platelet aggregation through a phospholipase C-calcium dependent signaling pathway. Arch Pharm Res 2007;30:210-4.
31. Liu J. Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 1995;49:57-68.
32. Wu PK, Chi Shing Tai W, Liang ZT, et al. Oleanolic acid isolated from Oldenlandia diffusa exhibits a unique growth inhibitory effect against ras-transformed fibroblasts. Life Sci 2009;85:113-21.
33. Yang YC, Wei MC, Huang TC. Optimisation of an ultrasound-assisted extraction followed by RP-HPLC separation for the simultaneous determination of oleanolic acid, ursolic acid and oridonin content in Rabdosia rubescens. Phytochem Anal 2012;23:627-36.
34. Hansen KF, Karelina K, Sakamoto K, et al. miRNA-132: a dynamic regulator of cognitive capacity. Brain Struct Funct 2013;218:817-31.
35. Lin LF, Chiu SP, Wu MJ, et al. Luteolin induces microRNA-132 expression and modulates neurite outgrowth in PC12 cells. PLoS ONE 2012;7:e43304.
36. Remenyi J, van den Bosch MW, Palygin O, et al. miR-132/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity. PLoS ONE 2013;8:e62509.
37. Shaltiel G, Hanan M, Wolf Y, et al. Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target. Brain Struct Funct 2013;218:59-72.
38. Smalheiser NR, Lugli G, Rizavi HS, et al. MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness. Int J Neuropsychopharmacol 2011;14:1315-25.
39. Numakawa T, Yamamoto N, Chiba S, et al. Growth factors stimulate expression of neuronal and glial miR-132. Neurosci Lett 2011;505:242-7.
40. Yang D, Li T, Wang Y, et al. miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression. J Cell Sci 2012;125:1673-82.
41. Luikart BW, Bensen AL, Washburn EK, et al. miR-132 mediates the integration of newborn neurons into the adult dentate gyrus. PLoS ONE 2011;6:e19077.
42. Arai M, Genda Y, Ishikawa M, et al. The miRNA and mRNA changes in rat hippocampi after chronic constriction injury. Pain Med 2013;14:720-9.
43. Li N, Liu RJ, Dwyer JM, et al. Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 2011;69:754-61.
44. O'Connor RM, Grenham S, Dinan TG, et al. microRNAs as novel antidepressant targets: converging effects of ketamine and electroconvulsive shock therapy in the rat hippocampus. Int J Neuropsychopharmacol 2013;16:1885-92.
45. Launay JM, Mouillet-Richard S, Baudry A, et al. Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16. Transl Psychiatr 2011;1:e56.
46. Hill MN, Hellemans KG, Verma P, et al. Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev 2012;36:2085-117.
47. Jimenez-Mateos EM, Bray I, Sanz-Rodriguez A, et al. miRNA expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am J Pathol 2011;179:2519-32.
48. Krützfeldt J, Kuwajima S, Braich R, et al. Specificity, duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res 2007;35:2885-92.
49. Fujioka T, Fujioka A, Duman RS. Activation of cAMP signaling facilitates the morphological maturation of newborn neurons in adult hippocampus. J Neurosci 2004;24:319-28.
50. Zuccato C, Belyaev N, Conforti P, et al. Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease. J Neurosci 2007;27:6972-83.
51. Johnson R, Zuccato C, Belyaev ND, et al. A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol Dis 2008;29:438-45.